| Name | Title | Contact Details |
|---|
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
Confluence Health is an integrated, rural healthcare delivery system with two hospitals, multi-specialty care in more than 30 service lines and primary care in 12 communities across North Central Washington. Our 250+ physicians and 150+ advanced practice clinicians serve an area of approximately 12,000 square miles and cover nearly every corner of the region through specialty outreach. Confluence Health is dedicated to improving our patients` health by providing safe, high-quality care in a compassionate and cost-effective manner. Core Values • Our patients are the reason for our being, and their needs will drive all of our actions. • We will treat everyone with dignity,respect and compassion. • We will continue to innovate ways to improve the delivery of excellent, high value care. • We will measure successes and failures, and use the results to drive further improvement. • We will be a good neighbor in the communities we serve with donations of time, talent, and capital. • We will be ethical and accountable in all of our decisions and actions.
Foss is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Seattle, WA. To find more information about Foss, please visit www.fosscare.org
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway.
Darena Solutions delivers an ecosystem of FHIR® enabled interoperability, regulatory compliance, and analytics solutions to healthcare providers and payers. By creating channels for data sharing between providers, payers, and patients, our solutions enable healthcare organizations to achieve compliance and derive insights to make prospective decisions resulting in increased workflow efficiencies and better patient outcomes.